IL21 and neoplasm: Compared to the nontreated control group, some antitumor effects were observed in the group treated with anti-PD-1 in CT26 tumor model, and the groups treated with anti-PD-1 or PD-1Ab combined with IL-21 in the MC38 tumor model.